Global, Regional, and National Burden of Pulmonary Arterial Hypertension, 1990-2021: a Systematic Analysis of the Global Burden of Disease Study 2021

Yafang Deng,Xingbei Dong,Junyan Qian,Jiuliang Zhao,Dong Xu,Yanhong WANG,Mengtao Li,Xiaofeng Zeng,Qian Wang
DOI: https://doi.org/10.1101/2024.10.25.24316118
2024-10-27
Abstract:Aims Pulmonary arterial hypertension (PAH) is a severe pulmonary vascular disease with high mortality rates. This research aimed to examine the disease burden of PAH including prevalence, incidence, mortality, and disability-adjusted life-years (DALYs) from 1990 to 2021 across various age groups, sexes, and Socio-demographic Index (SDI) levels, at global, regional and national levels. Methods Data was collected from the Global Burden of Diseases, Injuries, and Risk Factors study (GBD) 2021, which established models to estimate the burden of PAH for 204 countries and territories from 1990 to 2021. Age-standardized rates for PAH prevalence, incidence, mortality, and DALYs were calculated. Joinpoint regression was used to assess temporal trends. The correlation between disease burden and socioeconomic development was analyzed. Results In 2021, the global age-standardized prevalence and incidence rates were 2.28 and 0.52 per 100,000 population, respectively. From 1990 to 2021, the age-standardized mortality rate decreased from 0.35 to 0.27 per 100,000, with an average annual trend of -0.82%. The age-standardized DALY rate decreased from 13.21 to 8.24 per 100,000 by -1.52%. Females exhibited a higher incidence rate but lower mortality and DALY rates. The burden of PAH distributed unequally, with regions possessing higher socioeconomic statuses exhibiting lower mortality and DALY rates. Such inequalities have been improved over past decades. Conclusions The decline in mortality and DALY rates of PAH indicates improvements in disease management and patient outcomes, while the health inequalities among different regions and countries persist. Improving survival and life quality, and global health equality are crucial for future progress.
Cardiovascular Medicine
What problem does this paper attempt to address?
The paper attempts to address the comprehensive assessment of the global, regional, and national burden of pulmonary arterial hypertension (PAH) from 1990 to 2021, including prevalence, incidence, mortality, and disability-adjusted life years (DALYs). Specifically, the study aims to: 1. **Quantify the burden of PAH**: By analyzing data at the global, regional, and national levels, understand the trends in PAH prevalence, incidence, mortality, and DALYs. 2. **Explore gender and age differences**: Analyze the incidence, mortality, and DALYs of PAH across different genders and age groups to reveal their changing patterns. 3. **Assess the impact of socioeconomic factors**: Analyze the relationship between the Socio-demographic Index (SDI) and the burden of PAH, exploring the impact of socioeconomic development on PAH. 4. **Identify health inequality phenomena**: Evaluate the unequal distribution of the PAH burden across different regions and countries and explore the trends in these inequalities. Through these analyses, the study hopes to provide scientific evidence for future PAH screening, monitoring, and management strategies to improve patient survival rates and quality of life, and to promote global health equity.